AHGIF - Alternate Health Corp.
| Previous Close | 0.0649 |
| Open | 0.0771 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0771 - 0.0870 |
| 52 Week Range | 0.0580 - 0.6250 |
| Volume | 48,000 |
| Avg. Volume | 16,442 |
| Market Cap | 6.938M |
| Beta (5Y Monthly) | 0.11 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3670 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
Alternate Health Reports $3.1 Million in Third Quarter 2019 Revenue
Toronto, Ontario--(Newsfile Corp. - November 14, 2019) - Alternate Health Corp., (CSE: AHG) (OTCQB: AHGIF) ("Alternate Health" or the "Company"), an international leader in CBD product development and distribution, announced today that the Company generated $3.1 million in revenue in the third quarter of 2019. "Alternate Health's third quarter results demonstrate the Company's commitment to increasing revenues, expanding margins and developing new business opportunities," says Howard Mann, CEO of Alternate Health. "We have ...
- Newsfile
Alternate Health to Acquire Leading American CBD Manufacturer
Toronto, Ontario--(Newsfile Corp. - October 30, 2019) - Alternate Health Corp., (CSE:AHG) (OTCQB:AHGIF) ("Alternate Health" or the "Company"), an international leader in CBD product development and distribution, announced today that the Company has signed an agreement (the "Agreement") to acquire 51% of Mr. Custom White Label, LLC, ("MCWL"), a California-based white label / private label manufacturer of hemp-derived CBD products."In this acquisition, Alternate Health is securing a leading position in the global hemp-derived CBD ...
- Newsfile
Alternate Health Signs Supply Agreement Targeting 1,000 Kg Monthly of CBD Isolate and Distillate
Company launches international wholesale CBD distribution at AlternateCBD.com Toronto, Ontario--(Newsfile Corp. - September 26, 2019) - Alternate Health Corp. (CSE: AHG) (OTCQB: AHGIF) ("Alternate Health" or the "Company"), an international leader in CBD product development and distribution, announced today that the Company has launched a new wholesale CBD business line and signed a supply agreement targeting 1,000 kilograms of CBD per month. "Like many pharmaceutical companies, we have been disappointed with the supply of ...
- GlobeNewswire
European High Growth Opportunities Securitization Fund Converts Debentures of Alternate Health Corp.
European High Growth Opportunities Securitization Fund (the “Fund”) announced today the conversion of $400,000 of its aggregate $700,000 of Debentures (as defined below) of Alternate Health Corp. (“Alternate Health” or the "Company") (CSE:AHG) (OTCQB:AHGIF) on each of September 11, 2019 and September 16, 2019 (collectively, the “Conversions”) and the sale of an aggregate 645,840 Shares (as defined below) between September 11, 2019 and September 16, 2019. Pursuant to the terms of a financing arrangement (the “Financing”), the Company issued to the Fund a convertible debenture (the “Debenture”) in the principal aggregate amount of $700,000 and share purchase warrants (the “Warrants”) exercisable to acquire up to an aggregate of 3,348,484 common shares of the Company (the “Shares”).
- Newsfile
Alternate Health's Board Welcomes Leigh Valentine
Founder of Beauty Company With $300 Million in Sales Toronto, Ontario--(Newsfile Corp. - September 18, 2019) - Alternate Health Corp., (CSE: AHG) (OTCQB: AHGIF) ("Alternate Health" or the "Company"), an international leader in CBD product development and distribution, announced today that Leigh Valentine, internationally renowned entrepreneur beauty, has accepted a position on the Company's Board of Directors and will work with the Company to develop a line of branded CBD beauty products. "We are thrilled ...
- GlobeNewswire
CORRECTING and REPLACING – European High Growth Opportunities Securitization Fund Converts Debentures of Alternate Health Corp.
European High Growth Opportunities Securitization Fund (the “Fund”) announced today the conversion of $300,000 of its aggregate $700,000 of Debentures (as defined below) of Alternate Health Corp. (“Alternate Health” or the "Company") (CSE:AHG) (OTCQB:AHGIF) between July 23, 2019 and September 3, 2019 (collectively, the “Conversions”) and the sale of an aggregate 1,645,111 Shares (as defined below) between July 12, 2019 and September 6, 2019. Pursuant to the terms of a financing arrangement (the “Financing”), the Company issued to the Fund a convertible debenture (the “Debenture”) in the principal aggregate amount of $700,000 and share purchase warrants (the “Warrants”) exercisable to acquire up to an aggregate of 3,348,484 common shares of the Company (the “Shares”).
- CNW Group
Former Acting U.S. Attorney General Joins Alternate Health as Outside Counsel
TORONTO , Aug. 27, 2019 /CNW/ - Alternate Health Corp., ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in CBD product development and distribution, announced today that the Company has retained Matthew Whitaker , former acting Attorney General of the United States , and his law firm, Graves Garrett to act as Outside Counsel. Dr. Blaine, President of Alternate Health, commented: "Alternate Health is thrilled is welcome Matthew Whitaker as a key legal advisor while the Company divests our cannabis assets and focuses exclusively on hemp-derived CBD.
- CNW Group
Alternate Health reports $1.9 million of revenue in Q2 2019
Alternate Health reports $1.9 million of revenue in Q2 2019
- GlobeNewswire
European High Growth Opportunities Securitization Fund Closes Second Tranche of Financing Arrangement with Alternate Health Corp.
Pursuant to the terms of the Subscription Agreement, as part of the closing of the second tranche of the Financing, the Company issued to the Fund a convertible debenture (the “Debenture”) in the principal amount of $500,000 and share purchase warrants (the “Warrants”) exercisable to acquire up to 227,272 common shares of the Company (the “Shares”) for a period of three years at a price of $0.33 per Share. The Debenture and Warrants otherwise have the terms described in the Company’s press release dated June 14, 2019.
- CNW Group
Alternate Health Closes Second Tranche of Financing Agreement
TORONTO , July 17, 2019 /CNW/ - Alternate Health Corp., ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in CBD extraction, product development and distribution, announced today that the Company closed the second tranche of its financing arrangement with Alpha Blue Ocean as initially announced on June 14, 2019 and June 17, 2019 (the "Financing"), pursuant to the terms of an amended and restated subscription agreement dated July 3, 2019 (the "Subscription Agreement"). Pursuant to the Subscription Agreement, as part of the closing of the second tranche of the Financing, the Company issued to European High Growth Opportunities Securitization Fund ("EHGO") a convertible debenture (the "Debenture") in the principal amount of $500,000 and share purchase warrants (the "Warrants") exercisable to acquire up to 227,272 common shares of the Company (the "Shares") for a period of three years at a price of $0.33 per Share.
- CNW Group
Alternate Health Closes First Tranche of Financing Agreement
TORONTO , July 5, 2019 /CNW/ - Alternate Health Corp., ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in CBD extraction, product development and distribution, announced today that the Company closed the first tranche of its financing arrangement with Alpha Blue Ocean as initially announced on June 14, 2019 and June 17, 2019 (the "Financing"), pursuant to the terms of an amended and restated subscription agreement dated July 3, 2019 (the "Subscription Agreement"). Pursuant to the terms of the Subscription Agreement, as part of the closing of the first tranche of the Financing, the Company issued to European High Growth Opportunities Securitization Fund ("EHGO") a convertible debenture (the "Debenture") in the principal amount of $200,000 and share purchase warrants (the "Warrants") exercisable to acquire up to 3,121,212 common shares of the Company (the "Shares") for a period of three years at a price of $0.33 per Share.
CNW GroupDr. Blaine Joins Alternate Health as New President, Chief Medical Officer and Company Director
Dr. Blaine Joins Alternate Health as New President, Chief Medical Officer and Company Director
CNW GroupCanadian CBD Company Closes $20 Million U.S. Pharma Acquisition
TORONTO , June 20, 2019 /CNW/ - Alternate Health Corp., ("Alternate Health" "AHC" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in hemp-derived CBD extraction, product development and distribution, announced today that the Company has closed an amended acquisition agreement (the "Agreement") to acquire 100% of Blaine Labs Inc. (" Blaine Labs "). "I am excited to get started with Alternate Health, locking in the company's software solutions into our distribution system," says Dr. Robert Blaine , founder of Blaine Labs .
- CNW Group
Alternate Health Provides Update on Financing Agreement
TORONTO , June 17, 2019 /CNW/ - Alternate Health Corp., ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in hemp-derived CBD extraction, product development and distribution, announced today that the Company would like to provide an update on a financing facility agreement previously announced last Friday. On June 17, 2018 , Alternate Health issued a press release announcing that the Company had reached an agreement with Alpha Blue Ocean for a $5 million financing facility. Alternate Health expects the first tranche, as outlined in the agreement, to close within the next 10 business days.
CNW GroupAlternate Health Secures $5 Million Financing Facility from Alpha Blue Ocean
TORONTO , June 14, 2019 /CNW/ - Alternate Health Corp., ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in hemp-derived CBD extraction, product development and distribution, announced today that it has entered into an agreement to obtain funds to finance Alternate Health's expansion of its CBD product line and hemp extraction facility. "The Company is pleased to announce our financing agreement with Alpha Blue Ocean ," says Howard Mann , CEO of Alternate Health. "This agreement gives us capital to support our expanding CBD operations including manufacturing, distribution and new product development".
CNW GroupAlternate Health Expands Enterprise Sales of CBD Education Platform
Alternate Health Expands Enterprise Sales of CBD Education Platform
CNW GroupAlternate Health Announces Strategic CBD Positioning
TORONTO , May 16, 2019 /CNW/ - Alternate Health Corp., ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in CBD extraction, product development and distribution, announced today that the Company is restructuring its assets towards the potential $22 billion American CBD industry, and is focusing exclusively on hemp-derived cannabinoid extraction, and manufacturing and distributing proprietary medical grade products. "Alternate Health's foundational goal has always been to lead the cannabis industry in innovation and new product development, using the research garnered through our software to effectively and efficiently serve patients," says Howard Mann , CEO of Alternate Health.
CNW GroupAlternate Health Corp Targets CBD Industry With US$20 Million Blaine Labs Acquisition
Alternate Health Corp Targets CBD Industry With US$20 Million Blaine Labs Acquisition
CNW GroupAlternate Health announces latest innovation in cannabis tech
Alternate Health announces latest innovation in cannabis tech
- CNW Group
Alternate Health to Launch Cannabis Extraction at 60,000 SF State Licensed Facility in California
TORONTO , March 28, 2019 /CNW/ - Alternate Health Corp., ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in technology solutions for the regulated cannabis industry, announced today that the Company has signed two agreements to launch operations at a state licensed 60,000 square foot cannabis extraction facility in Adelanto, California . The agreement details the purchase of all of DTS's assets, extraction equipment and intellectual property, including the Dank Tank brand of extract vaporisers and cartridges.
CNW GroupAlternate Health Announces Private Placement
The Notes will bear simple interest at a rate of 8.5% per annum. Interest will accrue and be payable on the Maturity Date. The private placement proceeds will assist in funding Alternate Health's expansion into California's adult-use cannabis industry, including key acquisitions.
